{
    "clinical_study": {
        "@rank": "112453", 
        "arm_group": [
            {
                "arm_group_label": "Penicillin G", 
                "arm_group_type": "No Intervention", 
                "description": "hospitalization of 30 patients given penicilline intraveniously for 72 hours"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "30 hospitalized patients will be given placebo with a regular penicillin treatment"
            }, 
            {
                "arm_group_label": "Probiotic", 
                "arm_group_type": "Experimental", 
                "description": "Probiotics will be given to 30 hospitalized patients with regular penicillin treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The addition of probiotics to the routine therapy of Acute Pharyngotonsillitis in adult\n      patients may shorten the duration, and reduce the severity of the disease."
        }, 
        "brief_title": "The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Throat Pain", 
        "detailed_description": {
            "textblock": "Hypothesis The addition of probiotics to the routine therapy of AP in adult patients may\n      shorten the duration, and reduce the severity of the disease.\n\n      Study design A prospective, randomized, placebo-controlled, double-blinded study comparing\n      treatment with probiotics to placebo in patients with  AP.\n\n      The study will be conducted in accordance with the ethical standards of the Helsinki\n      Declaration and will be approved by the Human Experimentation Ethics Committee of the Ziv\n      Medical Center. Signed informed consent will be required from all patients before inclusion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age over 18 years\n\n          -  Acute pharyngotonsillitis for which hospitalization for intravenous antibiotic\n             treatment and/or fluids is needed\n\n        Exclusion Criteria:\n\n          -  Current therapy with systemic prednisone or equivalent at 20 mg/d for more than 10\n             days prior to inclusion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679366", 
            "org_study_id": "0054-11-ZIV"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo", 
                "description": "1 tablet 2 times daily", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Sugar pill for mimic probiotics"
            }, 
            {
                "arm_group_label": "Probiotic", 
                "description": "1 tablet twice daily", 
                "intervention_name": "Probiotics", 
                "intervention_type": "Drug", 
                "other_name": "BLIS"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 23, 2012", 
        "location": {
            "contact": {
                "email": "leonid.lv@ziv.health.gov.il", 
                "last_name": "Leonid Livshits, MD", 
                "phone": "+972506266061"
            }, 
            "contact_backup": {
                "email": "miron_da@clalit.org.il", 
                "last_name": "Dan Miron, Proff", 
                "phone": "+972508434337"
            }, 
            "facility": {
                "address": {
                    "city": "Safed", 
                    "country": "Israel"
                }, 
                "name": "Ziv Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients", 
        "overall_contact": {
            "email": "leonid.lv@ziv.health.gov.il", 
            "last_name": "Leonid Livshits, MD", 
            "phone": "+972506266061"
        }, 
        "overall_contact_backup": {
            "email": "miron_da@clalit.org.il", 
            "last_name": "Dan Miron, Proff", 
            "phone": "+972508434337"
        }, 
        "overall_official": {
            "affiliation": "Ziv Medical Center", 
            "last_name": "Leonid Livshits, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients will be followed daily while hospitalized. After discharge patients will fill a daily dairy for 10 days and record symptoms, signs, drinking, eating, and return to normal life. All dairies will be collected on day 10 of  the study.", 
            "measure": "period of disease", 
            "safety_issue": "Yes", 
            "time_frame": "10 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679366"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Follow-up throat culture, CBC, CRP, and ESR on day 4 of the study or at discharge if before. For patients with abnormal laboratory tests on admission, repeat tests are performed before discharge according to the routine of the department. For patients with normal tests on admission, these tests will be part of the study. For patients with Streptococcus pyogenes growth on admission and day 4 of the study, another throat culture will be done on day 10 of the study", 
            "measure": "analysis", 
            "safety_issue": "Yes", 
            "time_frame": "10 days"
        }, 
        "source": "Ziv Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ziv Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2011"
    }
}